Ras gene activation in human small intestinal tumors

Area of Science:

• Oncology
• Molecular Biology
• Gastroenterology

Background:

• The ras oncoprotein plays a role in cell signaling and cancer development.
• Investigating ras p21 expression and mutations in small intestinal tumors is crucial for understanding their pathogenesis.

Purpose of the Study:

• To investigate the expression of ras p21 oncoprotein in human small intestinal tumors.
• To detect H-ras and K-ras mutations in codon 12 and 13 in these tumors.
• To explore the potential role of ras p21 and H-ras mutations as molecular markers in small intestinal tumors.

Main Methods:

• Immunohistochemical technique using monoclonal antibody Y13-259 to analyze ras p21 levels.
• Polymerase chain reaction (PCR) to detect H-ras and K-ras mutations.
• Comparison of protein levels and mutation status between tumor tissues and adjacent normal tissues.

Main Results:

• Elevated ras p21 oncoprotein levels were observed in 9 out of 13 small intestinal tumors compared to normal tissue.
• H-ras gene mutations in codon 12 were identified in 4 out of 13 tumors, including a Brunner's gland adenoma, lymphoma, leiomyosarcoma, and metastatic adenocarcinoma.
• No K-ras mutations were found in codons 12 or 13.
• This study represents the first demonstration of ras mutations in small intestinal tumors.

Conclusions:

• Ras p21 oncoprotein may be involved in the pathogenesis of small intestinal tumors.
• H-ras mutations are present in a subset of small intestinal tumors.
• Ras p21 oncoprotein and H-ras mutations may serve as molecular genetic markers for small intestinal tumors.